Novo Nordisk launches Wegovy in India, targets obesity treatment...

Dununu.com Dununu

Sponsorluk

Novo Nordisk launches Wegovy in India, targets obesity treatment market, offers semaglutide-based weekly injection

RSS Feed Business

Posted

48

Novo Nordisk has launched Wegovy in India, an anti-obesity drug aimed at managing weight and reducing cardiovascular risks. Priced between Rs 17,345 and Rs 26,050 per month, the injectable drug targets India's large obese population. The company aims to create awareness and collaborate with stakeholders to combat obesity, citing its significant impact on India's GDP.

Read Full Article

Please log in to like, share and comment!

ICC Test Rankings: Pant registers career-high ranking, Bumrah holds firm

Rishabh Pant's historic twin centuries at Headingley propelled him to seventh in ICC Test...

By 0 2

Displaced families of Koshi Tappu submit petition to Prime Minister for compensation

KATHMANDU: Representatives of families displaced by the expansion of the Koshi Tappu Wildlife...

By 0 9

EĞİTİM BİLGİLERİ

TS LAWCET, PGLCET result 2025 releasing today at lawcet.tgche.ac.in: Check steps to download here

By 0 16

NATO chief sees a 'transformational' summit ahead despite differences over defense spending

By 0 17

Gill 'didn't quite have that on-field aura' as Kohli, Rohit: Nasser Hussain

Following India's defeat in the Leeds Test, former England captain Nasser Hussain critiqued...

By 0 25